{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:52:02Z","timestamp":1776811922538,"version":"3.51.2"},"reference-count":21,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T00:00:00Z","timestamp":1202256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> CAEBV is a high mortality and morbidity disease with life\u2010threatening complications. Nevertheless, the treatment regimens for CAEBV have not yet been established. Although some reports have described CAEBV therapy involving treatments such as antiviral drugs, immunomodulatory agents, and immunochemotherapy, none of these treatments have been demonstrated to be effective. The only treatment reported to be effective is allogeneic SCT. However, the complications of SCT are severe, so treatment results have been poor. Recently, immunotherapy has been devised, but this is still in the developmental stage. In this report, two cases of CAEBV in which allogeneic SCT was performed soon after diagnosis are reported. In both cases, a high EBV genome titer in the peripheral blood was detected at onset. After SCT, the EBV genome titer decreased as CTL activity gradually increased. This fact suggested that not only high\u2010dose chemotherapy as a preconditioning treatment of SCT but also increased CTL activity which could eliminate virus\u2010infected cells might be effective, although additional cases should be studied in order to establish effective treatments.<\/jats:p>","DOI":"10.1111\/j.1399-3046.2007.00873.x","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T08:14:22Z","timestamp":1202285662000},"page":"588-592","source":"Crossref","is-referenced-by-count":8,"title":["Two cases of chronic active Epstein\u2013Barr virus infection in which EBV\u2010specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation"],"prefix":"10.1111","volume":"12","author":[{"given":"Takako","family":"Miyamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Washio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Manki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008173430707"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(02)00112-9"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(86)90183-0"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.4049\/jimmunol.134.5.3082","article-title":"Characteristic T cell dysfunction in patients with chronic active Epstein\u2013Barr virus infection (chronic infectious mononucleosis)","volume":"134","author":"Tosato G","year":"1985","journal-title":"J Immunol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.2.280"},{"key":"e_1_2_5_7_2","first-page":"1165","article-title":"Clinicopathological states of Epstein\u2013Barr virus\u2010associated T\/NK\u2010cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults","volume":"24","author":"Suzuki K","year":"2004","journal-title":"Int J Oncol"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20398"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1882"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.2.443"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20622"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02488-0"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703392"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702600"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","article-title":"Quantitative analysis of Epstein\u2013Barr virus load by using a real\u2010time PCR assay","volume":"37","author":"Kimura H","year":"1999","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1240"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.3.971"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/367988"},{"key":"e_1_2_5_19_2","first-page":"200","article-title":"Immunodeficiency\u2010associated lymphoproliferative disorders","volume":"12","author":"Knowles DM","year":"1999","journal-title":"Mod Pathol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.4049\/jimmunol.163.10.5735","article-title":"Antigen\u2010driven expansion and contraction of CD8+\u2010activated T cells in primary EBV infection","volume":"15","author":"Hoshino Y","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.9.1395"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Role of cytotoxic T lymphocytes in Epstein\u2013Barr virus associated diseases","volume":"15","author":"Khanna R","year":"1997","journal-title":"Annu Rev Immunol"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3046.2007.00873.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3046.2007.00873.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T02:41:24Z","timestamp":1696905684000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3046.2007.00873.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,8]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1399-3046.2007.00873.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3046.2007.00873.x","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,8]]}}}